Kumar Anil, Harris Thurl E, Keller Susanna R, Choi Kin M, Magnuson Mark A, Lawrence John C
Department of Pharmacology, University of Virginia Health System, P.O. Box 800735, 1300 Jefferson Park Ave., Charlottesville, VA 22908, USA.
Mol Cell Biol. 2008 Jan;28(1):61-70. doi: 10.1128/MCB.01405-07. Epub 2007 Oct 29.
Rictor is an essential component of mTOR (mammalian target of rapamycin) complex 2 (mTORC2), a kinase complex that phosphorylates Akt at Ser473 upon activation of phosphatidylinositol 3-kinase (PI-3 kinase). Since little is known about the role of either rictor or mTORC2 in PI-3 kinase-mediated physiological processes in adult animals, we generated muscle-specific rictor knockout mice. Muscle from male rictor knockout mice exhibited decreased insulin-stimulated glucose uptake, and the mice showed glucose intolerance. In muscle lacking rictor, the phosphorylation of Akt at Ser473 was reduced dramatically in response to insulin. Furthermore, insulin-stimulated phosphorylation of the Akt substrate AS160 at Thr642 was reduced in rictor knockout muscle, indicating a defect in insulin signaling to stimulate glucose transport. However, the phosphorylation of Akt at Thr308 was normal and sufficient to mediate the phosphorylation of glycogen synthase kinase 3 (GSK-3). Basal glycogen synthase activity in muscle lacking rictor was increased to that of insulin-stimulated controls. Consistent with this, we observed a decrease in basal levels of phosphorylated glycogen synthase at a GSK-3/protein phosphatase 1 (PP1)-regulated site in rictor knockout muscle. This change in glycogen synthase phosphorylation was associated with an increase in the catalytic activity of glycogen-associated PP1 but not increased GSK-3 inactivation. Thus, rictor in muscle tissue contributes to glucose homeostasis by positively regulating insulin-stimulated glucose uptake and negatively regulating basal glycogen synthase activity.
Am J Physiol Endocrinol Metab. 2006-1
Genes (Basel). 2025-8-11
Front Endocrinol (Lausanne). 2025-2-10
Curr Issues Mol Biol. 2023-9-30
Sports Med Health Sci. 2022-12-1
Cancers (Basel). 2022-11-10
Front Pharmacol. 2022-8-31
Dev Cell. 2022-3-28
Cell Metab. 2007-4
Nat Cell Biol. 2007-3
Cell Signal. 2007-1
Cell. 2006-2-10
Diabetes. 2005-12